Trial Profile
SUBA-itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses: a Multi-center, Open-label Comparative Trial
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Oct 2022
Price :
$35
*
At a glance
- Drugs Itraconazole (Primary)
- Indications Mycoses
- Focus Adverse reactions; Pharmacokinetics
- 13 May 2022 Status changed from active, no longer recruiting to completed.
- 23 Dec 2021 Planned End Date changed from 31 Oct 2021 to 1 Apr 2022.
- 21 Sep 2021 Planned End Date changed from 31 May 2020 to 31 Oct 2021.